Stablepharma, the Fridge-free Vaccine Company, is delighted to announce another new member to the Team. Richard Amaee joins as Programme Manager and will be responsible for the development of Stablepharma’s reformulated, fridge-free SPVX02 vaccine for Tetanus diphtheria, working closely with our Chief Scientific Officer (CSO), Dr Arcadio Garcia de Castro. “This is great news for […]
Read More
Professor Saul Faust, consultant paediatrician at University Hospital Southampton, has been recognised for his research into vaccines which helped determine how safe and effective they were before being rolled out. He was presented the accolade by the Prince of Wales last week after it was announced last year in the Queen’s Jubilee Honour’s List. Southampton […]
Read More
Stablepharma considers IPO, Series B round to bring vaccines to market – CEO 08:00 CEST, 5 April 2023 Stablepharma, a UK developer of the world’s first fridge-free vaccines, is evaluating an IPO and a financing round to bring two vaccines to market, CEO Özgür Tuncer told Mergermarket. The business will take a decision after the summer […]
Read More